A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.

@article{Tsukamoto2006API,
  title={A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.},
  author={Hiroshi Tsukamoto and Koji Nagafuji and Takahiko Horiuchi and Toshihiro Miyamoto and Kazunari Aoki and Ken Takase and Hideho Henzan and Daisuke Himeji and Tomiko Koyama and Kohei Miyake and Yumiko Inoue and Hitoshi Nakashima and Takeshi Otsuka and Yoshiya Tanaka and Kohei Nagasawa and M. D. N. Harada},
  journal={Annals of the rheumatic diseases},
  year={2006},
  volume={65 4},
  pages={508-14}
}
OBJECTIVES To carry out a phase I-II trial to elucidate the feasibility and efficacy of high dose cyclophosphamide (CY) supported by autologous peripheral blood stem cell transplantation (PBSCT) in the treatment of severe and refractory autoimmune disease (AD). METHODS Peripheral blood stem cells (PBSCs) were mobilised during haematological recovery after… CONTINUE READING